Screener
R&D at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Resideo Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Resideo Technologies, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 5:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001740332-26-000018
| (in millions, except per share data) | Three Months Ended / April 4, 2026 | Three Months Ended / March 29, 2025 |
|---|---|---|
| Cost of goods sold | 1,361 | 1,259 |
| Gross profit | 551 | 511 |
| Operating expenses: | ||
| Research and development expenses | 48 | 35 |
| Selling, general and administrative expenses | 340 | 306 |
| Intangible asset amortization | 31 | 30 |
| Restructuring expenses | 6 | 4 |
| Business separation costs | 24 | — |
Item 1. Unaudited Consolidated Financial Statements.
FAQ
- What is Resideo Technologies, Inc.'s R&D?
- Resideo Technologies, Inc. (REZI) reported R&D of $48M in Q1 2026.
- How has Resideo Technologies, Inc.'s R&D changed year-over-year?
- Resideo Technologies, Inc.'s R&D increased by 37.1% year-over-year, from $35M to $48M.
- What is the long-term trend for Resideo Technologies, Inc.'s R&D?
- Over 4 years (2021 to 2025), Resideo Technologies, Inc.'s R&D has grown at a 18.0% compound annual growth rate (CAGR), from $86M to $167M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Resideo Technologies, Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude